Obesity Clinical Trial
— BCSPOfficial title:
The Impact of Abdominal Body Contouring Surgery on Physical Function After a Massive Weight Loss: a Non-randomized Control Trial
NCT number | NCT04516473 |
Other study ID # | H20-00960 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | August 18, 2020 |
Est. completion date | December 29, 2021 |
Verified date | January 2022 |
Source | University of British Columbia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Obesity is a growing chronic medical condition in which as of 2015, a total of 107.7 million children and 603.7 million adults were considered obese and since 1980 the prevalence of obesity has doubled in more than 70 countries. It is estimated that 70 percent of individuals who undergo a massive weight loss would develop excess skin and based on patient reported outcome measures, it has been shown that excess skin negatively impacts patients' body image, self-esteem, physical function and body contouring surgeries have been demonstrated to improve these measures. These are surgeries that correct for excess skin and its adverse consequences. The form of the surgery is case dependent and can range from removing an apron of skin to complete contouring of the abdomen with tightening of the abdominal muscle and moving the belly button. Despite previous studies indicating mobility limitation because of excess skin and improvements after abdominal body contouring surgeries with the use of subjective measures of physical function, there are no studies that directly measures physical fitness post body contouring surgeries. Therefore, the purpose of the current study is to evaluate the impact of abdominal body contouring surgeries on direct objective measures of physical function. It is hypothesized that 1) the removal of excess skin will improve direct objective measures of physical function in post massive weight loss participants 2) the removal of excess skin will improve direct measures of gait and balance in post massive weight loss participants 3) the removal of excess skin will improve patient reported outcome measures using quality of life questionnaires in post massive weight loss participants 4) the removal of excess skin will improve aerobic capacity in post massive weight loss participants 5) the removal of excess skin does not change the body composition in post massive weight loss participants.
Status | Completed |
Enrollment | 27 |
Est. completion date | December 29, 2021 |
Est. primary completion date | December 29, 2021 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Weight has not deviated by greater than 5 percent for 3 months - Have excess grade skin of greater or equal to 2 - Percent total weight loss pre-body contouring of greater or equal to 25 percent - Fluently read and write English Exclusion Criteria: - Any musculoskeletal issues that would prevent participants from doing the physical function tests. - Current medication history indicating atypical antipsychotics including but not limited to clozapine, olanzapine, quetiapine, risperidone, aripiprazole, amisulpride, ziprasidone, asenapine, iloperidone, lurasidone and paliperidone. - Severe pulmonary conditions such as severe chronic obstructive pulmonary disease (COPD) and or severe asthma. - Participants who actively aiming to lose weight - Have diabetes with diabetic neuropathy or experienced hypoglycemic event within 6 months prior to the study - Severe kidney disease with estimated glomerular filtration rate (eGFR) less than 60 ml/min - Pregnant individuals - Uncontrolled hypertension with resting blood pressure greater than 160/90 mmHg - Uncontrolled obstructive sleep apnea with symptoms - On statin therapy with myopathy - Unstable atrial fibrillation - Weight pre-body contouring greater than 340 lbs (154 kg) - Current smoker |
Country | Name | City | State |
---|---|---|---|
Canada | University of British Columbia | Vancouver | British Columbia |
Lead Sponsor | Collaborator |
---|---|
University of British Columbia |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Correlation between degree of excess skin and change in objective physical function test scores | Measured by linear models and correlating the degree of excess skin and change in measures of physical function scores from post to pre surgery | 8-12 weeks | |
Other | Correlation between the weight of resected excess skin and change in objective physical function tests | Measured by linear models and correlating the amount of weight of the resected excess skin and change in measures of physical function scores from post to pre surgery | 8-12 weeks | |
Primary | Change in physical function aggregate score | Measured by 9-item modified physical performance test that gives an aggregate score out 36 and comprises of 9 tests pre and post surgery and includes the following:
Time to complete a book lift Time to complete putting on/off a lab coat Time to complete picking up a penny from the floor Time to complete a 5 times chair stand Turning 360 degrees Time to complete a 50 feet walk Time to complete 1 flight of stairs Completing 4 flights of stairs A progressive romberg test Lowest score is 0, highest score is 36 and higher scores represent better outcomes. |
8-12 weeks | |
Secondary | Change in lower body strength | Measured by number of stands completed during a 30 seconds chair stand pre and post surgery | 8-12 weeks | |
Secondary | Change in time to complete agility drill | Measured by time to complete a modified agility t-test pre and post surgery | 8-12 weeks | |
Secondary | Change in timed up and go | Measured by time to complete a timed up and go test | 8-12 weeks | |
Secondary | Change in stair climbing power | Measured by time to ascend 10 stairs and deriving power pre and post surgery | 8-12 weeks | |
Secondary | Change in dynamic balance balance | Measured by star excursion balance test pre and post surgery | 8-12 weeks | |
Secondary | Change in aerobic capacity | Measured by distance traveled during a 6 minute walk test pre and post surgery | 8-12 weeks | |
Secondary | Change in lean body mass | Measured by change in bone free fat mass by using dual-energy X-ray absorptiometry pre and post surgery | 8-12 weeks | |
Secondary | Change in fat mass | Measured by using dual-energy X-ray absorptiometry pre and post surgery | 8-12 weeks | |
Secondary | Change in patient reported outcome measure of physical function and quality of life | Measured by 6 health related quality of life components of BODY-Q questionnaire pre and post surgery. Sub-scales would include body image, physical function, psychological, sexual, social, and obesity/physical symptoms. Each sub-scale will be graded individually, and the raw scores will be converted into a score from 0-100. For body image, physical function, psychological function, sexual, and social function higher scores represent a better outcome
For obesity/physical symptoms, symptoms will be added so that the total number of symptoms experienced would be obtained. Minimum number of symptoms is 0 and maximum is 10. |
8-12 weeks | |
Secondary | Change in rate of perceived exertion (RPE) during physical function tests | Measured by BORG RPE scale pre and post surgery. Minimum score is 6 and maximum is 20. The scale is only to provide how much the participants are being exerted when given a task. | 8-12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |